Navigation Links
Business Opportunities in Spain's Fast-Growing Biotechnology Industry
Date:7/9/2009

MADRID, July 9 /PRNewswire/ --

- INVEST IN SPAIN would like to invite you to take part in an online seminar entitled "Business Opportunities in the Biotechnology, Pharma and Life Sciences Sector", in which business opportunities will be presented for foreign companies in the sector in Spain. Experts will respond to the questions of participants live.

- The seminar will be held on the 14th of July (12:00pm - 1:30pm Eastern Day Time or 6:00pm - 7:30pm Central European Time (GMT+1 in Spain)

- In order to attend the seminar, you have to first register for free using the following link: http://www.xtalks.com/events/xto341spain3/reg1.html

The biotechnology sector is one of the most dynamic in Spain. It has maintained an annual growth rate for turnover and job creation of 30% according to data from ASEBIO, the Spanish Association of Bio-companies. Spain attracts international projects and financing in biotechnology because it has a solid scientific base, highly qualified workforce, integrated health system, state-of-the-art infrastructures for innovation and major governmental backing. A fast-growing industry in a country with an extraordinary quality of life.

Business opportunities in Spain over the coming years will be linked to fields such as personalized medicine and advanced therapies, where interest is increasing in molecular diagnoses and related products.

In order to analyze opportunities in this field, the following people will participate in the online seminar: Jose Navas, Director of the Carlos III Health Institute, renowned for research into Cellular Therapy and Regenerative Medicine, and Eduardo Bravo, CEO of Cellerix, a company success story for foreign investment being as it is a Spanish company renowned internationally and with the participation of a range of foreig
'/>"/>

SOURCE Invest in Spain
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. China Clean Energy Provides Business Update
2. Encorium Group Updates Expected Timeframe with Respect to the Sale of its U.S. Business
3. SenesTech Announces New Vice President of Business Development
4. Gerresheimer Sells Technical Plastics Business
5. OmniComm Systems Announces Acquisition of EDC Business of eResearchTechnology
6. NeoStem Featured in Business Week; Promising Adult Stem Cell Market Discussed in Fortune-CNNMoney.com Article
7. WuXi PharmaTech Appoints Wei-Min Chang as Vice President of Operations and General Manager of SynTheAll Manufacturing Facility, Eric Gu as Vice President of Business Development for Manufacturing Services
8. CoreRx, Inc. Announces Plans for Expansions to Meet the Needs of Growing Pharmaceutical Formulation Development Business
9. Next Stage Solutions Announces Three New Financial Services For Emerging Business
10. SIRO Group Appoints Scott L. Spector as President, Strategic Operations, for its European Business
11. Neptune Technologies Reports Fiscal 2009 Results - Record revenue and profitability growth in nutraceutical business

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/23/2009)...Y,N.C.,Nov.23/PRNewswire-FirstCall/--CornerstoneTh...icalcompanyfocusedonacquiring,developingandcommerc...oryandrelatedmarkets,todayannouncedthatCraigA.Coll...tingacorporateoverviewatthe21stAnnualPiperJaffrayH...,2009atTheNewYorkPalaceHotelinNewYorkCity. ,, A...
(Date:11/20/2009)..., ROCKVILLE, Md., Nov. 20 /PRNewswire-FirstCall/ -...hat it has priced an underwritten public offering ... to the public of $3.30 per share. The approximat...he underwriting discounts and commissions, will be...of our VLP-based vaccines, internal research and d...
(Date:11/19/2009)...ople would like to be able to charge their cell ph...t too often. A recent discovery made by UC San Die...upercapacitors that could do just this. , In re...rs , Prabhakar Bandaru, a professor in the UCSD De...along with graduate student Mark Hoefer, have foun...
(Date:11/19/2009)...NEW YORK, Nov. 19 NeoSte...t has sent the following letter to its shareholder...r 30, 2009, of China Biopharmaceuticals Holdings, ...any based in the People,s Republic of China. The m...Suzhou Eyre Pharmaceutical Co. Ltd., CHBP,s primar...
Breaking Biology Technology:Cornerstone Therapeutics to Present at the 21st Annual Piper Jaffray Health Care Conference 2Novavax Prices Public Offering of Common Stock 2Nanotube defects equal better energy and storage systems 2NeoStem Outlines to Shareholders Near-term and Long-term Business Strategies Following Acquisition of Chinese Pharmaceutical Company 2NeoStem Outlines to Shareholders Near-term and Long-term Business Strategies Following Acquisition of Chinese Pharmaceutical Company 3
...M), a developer of follow-on biologics and biophar...nd questionnaire from the Chairman and,Ranking Mem...ttee on Health,on the possible development of legi...regulatory pathway., Sent to approximately 30 sta... and patient communities, the letter notes that th...
...date -, PRINCETON, N.J., April 10, 2008 Laureate...elopment and protein production,company, today ann...nufacturing agreement with Alopexx Pharmaceuticals...roduce Alopexx,s mAb F598 antibody under cGMP,cond...al trials, and later,for commercial production for...
...y become easier, thanks to chemical sensors being ... led by chemistry professor Theodore Goodson III h...ff signals that can be detected remotely---from a ...y described in the journal Nanotechnology and also...ional meeting of the American Chemical Society in ...
Other Biology Technology:Insmed Selected to Complete Congressional Questionnaire Regarding the Potential Establishment of a Follow-On Biologics Regulatory Pathway 2Insmed Selected to Complete Congressional Questionnaire Regarding the Potential Establishment of a Follow-On Biologics Regulatory Pathway 3Laureate Pharma Announces Manufacturing Agreement With Alopexx Pharmaceuticals, LLC 2Laureate Pharma Announces Manufacturing Agreement With Alopexx Pharmaceuticals, LLC 3Safer, easier system for remote explosive detection 2
(Date:11/23/2009)...hern California biomedical engineer and cardiologi...to help clinicians distinguish cardiac emergencies... manageable with drugs and lifestyle change. , A...the arteries feeding the heart, offer an inside vi...d vessels, often revealing deposits of a dangerous...
(Date:11/23/2009)...te of General Medical Sciences (NIGMS), part of th...g $42.3 million for grants in scientific areas it ...loped the GO grant program to stimulate biomedical...the American Recovery and Reinvestment Act (Recove...mise to have a significant impact on a field of bi...
(Date:11/23/2009)...sabona is Director of the Interuniversity Professo...rsity and the University of the Basque Country. Th...also has other experts such as researchers in the ...cialists in ethics. , The Interuniversity Profes...sities of Deusto and the Basque Country was create...
Breaking Biology News(10 mins):Stable plaque or heart attack plaque? USC researcher builds new sensor to tell which is which 2NIGMS invests in scientific Grand Opportunities with Recovery Act funds 2NIGMS invests in scientific Grand Opportunities with Recovery Act funds 3Research and legislation should go hand in hand, as much as possible 2Waters Drives Efficiency in the Clinical and Research Laboratory and Showcases New MassTrak Systems at AACC 2009 52119 1Waters Drives Efficiency in the Clinical and Research Laboratory and Showcases New MassTrak Systems at AACC 2009 52119 2Waters Drives Efficiency in the Clinical and Research Laboratory and Showcases New MassTrak Systems at AACC 2009 52119 3Waters Drives Efficiency in the Clinical and Research Laboratory and Showcases New MassTrak Systems at AACC 2009 52119 4Promising new treatment for Alzheimers suggested based on Hebrew University research 9283 1Promising new treatment for Alzheimers suggested based on Hebrew University research 9283 2Slotted buses keep passengers cool 9279 1Slotted buses keep passengers cool 9279 2
...ruggling with what humans have done to the modern ... according to Professor Greg Gibson,s recently pub... Between Our Genes and Modern Life Is Making Us Si...cal Sciences, suggests the increased rates of dise...due to human genes being unable to cope with the 2...
...MIPAS and GOME-2 instruments, scientists have for ...in the atmosphere. These new measurements will hel...-depleting species and to improve simulations of s...tion of bromine monoxide (BrO) in the atmosphere s...st observed in 2008 when scientists from the Karls...
...Biometric Technology In Support of the Warfighter ...pplications International Corporation (NYSE: SAI...ct by Sensor Technologies Incorporated (STI) to su... Command (CECOM) by providing operations and user ... (TBS). SAIC,s subcontract has a one-year base pe...
Other Biology News:'It takes a genome: How a clash between our genes and modern life is making us sick' 2European satellites provide new insight into ozone-depleting species 2SAIC Awarded $115 Million Subcontract to Support Tactical Biometrics Systems (TBS) 2
...r real-time or pre-programmed liquid switching in ...y, or general liquid-handling research application...econd accuracy Run experiments automatically - ev...nd flexibility Turnkey perfusion system includes ...
Human PTP1B, aa 2-321 Carrier Free from R&D Systems
... the basic components required for the development...nant rat Thymus Chemokine-1 in cell culture supern...ials to run ELISAs on approximately fifteen 96-wel...re met: The assay is run as summarized in the Ge...
Anti-FGF Receptor 1 Antibody, Unconjugated from Cell Signaling Technology
Biology Products: